Beyond vasoconstriction, ET-1 contributes to vascular inflammation, cardiac hypertrophy, and disease progression in hypertension, chronic kidney disease, and atherosclerosis (Figure 5) [62,63,64]. This evidence concerns the gene EDN1 and cardiac hypertrophy.